Pigmentary disorders and keloids can be signs of systemic disease and can cause significant psychological impact and social ramifications. Panelists will discuss the breadth of pigmentary disorders, including vitiligo, melasma, and post-inflammatory hyperpigmentation, and utilize global scientific literature to update the audience on newer therapeutic options.
Upon completion of this webinar you will be able to:
- Define and discuss the pathogenesis, diagnosis, and treatment of pigmentary disorders, including vitiligo.
- Define and discuss the pathogenesis, diagnosis, and treatment of keloids and hypertrophic scarring.
- Illustrate how keloids and pigmentary disorders have psychological, socioeconomic, and cultural impact, and increased health disparities in people of color.
- Summarize global scientific literature on research and newer therapeutic options in pigmentary disorders.
Moderator: Seemal R. Desai, MD, FAAD
Panelists: Pearl E. Grimes, MD, and Donald A. Glass II, MD, PhD
Panelists (Patient Stories): Dhaval Desai, MD, and Titilola Sode, MD